Medicare Enrolled

Dr. Lisa Wang, M.D.

Hematology & Oncology · Whittier, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
12462 PUTNAM ST, Whittier, CA 90602
5627895480
In practice since 2007 (18 years)
NPI: 1356549331 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wang

Dr. Lisa Wang is a hematology & oncology specialist in Whittier, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Wang performed 6,065 Medicare services across 1,027 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wang received a total of $1,150 from 21 pharmaceutical and/or device companies across 49 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 32% volume in CA $1,150 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,065
Medicare services
Top 32% in CA for hematology & oncology
1,027
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~337 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,060 $18 $34
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
851 $12 $49
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
558 $1 $13
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
350 $97 $356
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
265 $68 $253
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
258 $147 $499
Blood sample collection from implanted device
This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body.
164 $24 $80
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
104 $8 $13
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
65 $65 $191
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
61 $100 $281
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
51 $33 $50
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
48 $76 $153
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
47 $41 $111
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
42 $143 $530
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
36 $0 $42
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
34 $15 $123
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
22 $27 $80
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
19 $21 $75
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
17 $109 $444
New patient office visit, complex (60-74 min) 13 $188 $610
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,150
Total received (2018-2024)
Avg $192/year across 6 years
Bottom 36% in CA for hematology & oncology
21
Companies
49
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$984 (85.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$166 (14.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$868
2022
$43
2021
$112
2020
$39
2019
$49
2018
$41

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$166
Novartis Pharmaceuticals Corporation
$162
Janssen Biotech, Inc.
$94
AstraZeneca Pharmaceuticals LP
$72
EMD Serono, Inc.
$47
PFIZER INC.
$43
Exelixis Inc.
$36
Novocure Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$35
JAZZ PHARMACEUTICALS INC.
$33
Daiichi Sankyo Inc.
$29
Tempus AI, Inc
$26
GENZYME CORPORATION
$26
Deciphera Pharmaceuticals Inc.
$24
Eisai Inc.
$22
Cranial Technologies, Inc
$16
Top 3 companies account for 48.7% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$166
Novartis Pharmaceuticals Corporation
$162
PFIZER INC.
$147
Janssen Biotech, Inc.
$137
AstraZeneca Pharmaceuticals LP
$72
Amgen Inc.
$59
EMD Serono, Inc.
$47
Exelixis Inc.
$36
Novocure Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$35
JAZZ PHARMACEUTICALS INC.
$33
Daiichi Sankyo Inc.
$29
Tempus AI, Inc
$26
GENZYME CORPORATION
$26
Sanofi Pasteur Inc.
$25
Karyopharm Therapeutics Inc.
$25
Deciphera Pharmaceuticals Inc.
$24
Eisai Inc.
$22
Cranial Technologies, Inc
$16
Genentech USA, Inc.
$16
Gilead Sciences, Inc.
$12
Top 3 companies account for 41.4% of all-time payments
Associated products mentioned in payments ›
BRAFTOVI · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · DARZALEX · Doc Band · ERLEADA · Enhertu · Fabhalta · IMBRUVICA · INLYTA · KEYTRUDA · KISQALI · LORBRENA · Lenvima · MEKINIST · NINLARO · NO PRODUCT DISCUSSED · Nplate · Optune Lua (NovoTTF-200T) · PLUVICTO · QINLOCK · SARCLISA · TECENTRIQ · VIZIMPRO · XPOVIO · XT CDX · XTANDI · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Whittier?
Compare hematology & oncology specialists in the Whittier area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
393
Per 100K population
4.0
County median income
$87,760
Nearest hospital
PIH HEALTH HOSPITAL-WHITTIER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wang is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wang experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Wang performed 3,060 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $1,150 from 21 companies across 49 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other hematology & oncology specialists in Whittier?
Dr. Wang's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →